Late Complications from Chemoradiotherapy for Cervical Cancer: Reflections from Cervical Cancer Survivors 10 Years after the National Cancer Institute Alert

Clinical Oncology

Volumn 22, Issue 7, 2010, Pages 588-589

  Vale, C ^a   Nightingale, A ^a   Spera, N ^a   Whelan, A ^a   Hanley, B ^b   Tierney, J F ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b TwoCan Associates   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

BLADDER DISEASE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL DISEASE; DISEASE SEVERITY; EDITORIAL; HUMAN; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION INJURY; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNITED KINGDOM; UTERINE CERVIX CANCER; VAGINA DISEASE;

EID: 77955654743     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.05.017     Document Type: Editorial

References (5)

1. National Cancer Institute NCI issues clinical announcement on cervical cancer: chemotherapy plus radiation improves survival 1999.
2. Goonatillake S., Khong R., Hoskin P. Chemoradiation in gynaecological cancer. Clin Oncol 2009, 21(7):566-572.
3. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008, 26(35):5802-5812. Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration.
4. Vale CL, Tierney JF, Davidson SE, Drinkwater KJ, Symonds P. Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists' audit. Clin Oncol, in this issue.
5. Davidson S.E., Trotti A., Ataman O.U., et al. Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2007, 69:1218-1221.